PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'1st Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, Evangelismos Hospital, National and Kapodistrian University of Athens, Athens, Greece.\', \'Department of Immunology and Histocompatibility, \'Evangelismos\' General Hospital, Athens, Greece.\', \'1st Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, Evangelismos Hospital, National and Kapodistrian University of Athens, Athens, Greece; 2nd Department of Critical Care Medicine, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece.\', \'1st Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, Evangelismos Hospital, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: akotanid@med.uoa.gr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0042-6822(21)00002-710.1016/j.virol.2021.01.002
?:hasPublicationType
?:journal
  • Virology
is ?:pmid of
?:pmid
?:pmid
  • 33550117
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.728
?:rankingScore_hIndex
  • 159
?:title
  • A novel ratio of CD8+:B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all